leisure time -WSS

leisure time

author：explore 2025-09-28 01:37:59 - browse：48698

The Federal Trade Commission office glows softly inside, contrasting with the darkness outside — coverage from STAT — Adobe

Over the past two decades, hundreds of hospital mergers have escaped federal antitrust scrutiny and led to both higher prices and less competition, a new study shows.

But the study’s authors, and other researchers, believe the Federal Trade Commission’s hands often are tied. The agency simply doesn’t have enough money or people to crack down on all anticompetitive hospital deals, and some state laws shield hospital mergers from federal review completely.

“The resources available are just not commensurate with what the agency needs,” said Zack Cooper, an associate professor of health policy and economics at Yale University and one of the co-authors of the study. “This isn’t a story of the FTC not knowing what to do. I actually think they really know, very clearly, what to do. It’s a lack of resources, person power, and potentially willingness to do it.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Readout LOUD podcast: ASCO preview, a Duchenne trial failure

focus

WSS

Hottest summer in 2,000 years puts focus on extreme heat, health

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

FDA's Pazdur wants cancer trials to range beyond China alone

HHS suspends federal funding for EcoHealth Alliance

Fertility clinic egg and embryo storage is a disaster

WuXi Biologics beefs up its lobbying operation

hotspot

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

New air purifier tech could be key to improving indoor air quality

With trial win, GSK could get blood cancer drug back on market

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Obesity drug from Roche shows promise in early study

The cancer drug shortage isn’t new — and neither are the solutions

Ionis drug prevents swelling attacks due to hereditary angioedema

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

As demand for Covid shots wanes, Moderna seeks its next success

NIH documents show early flaws of $1.6 billion long Covid program

Wikipedia

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Intellia reports positive results for its CRISPR

Boston hospital trains restaurant workers on naloxone for overdoses

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Hottest summer in 2,000 years puts focus on extreme heat, health

How to increase colonoscopy rates? Looks like an AI can help

leisure time

focus

entertainment

hotspot